

Mondelez vs Kimberly-Clark
Mondelez International sells snacks, cookies, and chocolate under beloved brands like Oreo, Cadbury, and Toblerone to consumers in over 150 countries, using pricing power and emerging market growth to drive earnings, while Kimberly-Clark produces tissue, diapers, and personal care products that consumers replenish out of necessity rather than indulgence. Both companies are classic consumer staples compounders, using global distribution and brand loyalty to pass through cost inflation and generate reliable cash flows. The Mondelez vs Kimberly-Clark comparison examines how a snacking powerhouse and a tissue and hygiene giant compare on organic growth, pricing dynamics, and capital return strategies.
Mondelez International sells snacks, cookies, and chocolate under beloved brands like Oreo, Cadbury, and Toblerone to consumers in over 150 countries, using pricing power and emerging market growth to...
Why It's Moving

Analysts Rally Behind MDLZ with Strong Buy Consensus Pointing to Solid Upside Potential.
- Over 40 analysts deliver a Strong Buy consensus, driven by 18 buys versus just 9 holds and zero sells, highlighting robust faith in MDLZ's snacking portfolio resilience.
- Median price targets cluster around $67-$70 from today's price, implying 15-16% upside and underscoring expectations for margin recovery post-cost pressures.
- JPMorgan and Jefferies stand out with overweight/buy calls ahead of earnings, citing improving food sector dynamics in late 2026 despite lingering cocoa headwinds.

Kimberly-Clark Stock Faces Mixed Analyst Outlook as UBS Trims Price Target Amid Revenue Headwinds
- UBS Group cut its price target to $105 from $110 with a maintained neutral rating, joining multiple brokerages in trimming forecasts recently as revenue declined 0.6% year-over-year
- The company beat earnings estimates with Q1 EPS of $1.86 but posted a revenue miss, raising concerns about demand headwinds offset by operational efficiency
- Analyst consensus remains split with 3 buys, 11 holds, and 1 sell among recent ratings, though the stock's high debt-to-equity ratio of 3.97 is weighing on investor sentiment

Analysts Rally Behind MDLZ with Strong Buy Consensus Pointing to Solid Upside Potential.
- Over 40 analysts deliver a Strong Buy consensus, driven by 18 buys versus just 9 holds and zero sells, highlighting robust faith in MDLZ's snacking portfolio resilience.
- Median price targets cluster around $67-$70 from today's price, implying 15-16% upside and underscoring expectations for margin recovery post-cost pressures.
- JPMorgan and Jefferies stand out with overweight/buy calls ahead of earnings, citing improving food sector dynamics in late 2026 despite lingering cocoa headwinds.

Kimberly-Clark Stock Faces Mixed Analyst Outlook as UBS Trims Price Target Amid Revenue Headwinds
- UBS Group cut its price target to $105 from $110 with a maintained neutral rating, joining multiple brokerages in trimming forecasts recently as revenue declined 0.6% year-over-year
- The company beat earnings estimates with Q1 EPS of $1.86 but posted a revenue miss, raising concerns about demand headwinds offset by operational efficiency
- Analyst consensus remains split with 3 buys, 11 holds, and 1 sell among recent ratings, though the stock's high debt-to-equity ratio of 3.97 is weighing on investor sentiment
Investment Analysis

Mondelez
MDLZ
Pros
- Mondelez has a strong global brand portfolio including Oreo, Ritz, and CLIF Bar, supporting resilient top-line growth across diverse markets.
- The company showed an adjusted EPS beat in Q3 2025 despite inflationary cost pressures, indicating operational profitability resilience.
- Recent market valuation metrics suggest Mondelez is undervalued by about 64.6% based on discounted cash flow analysis, signaling potential long-term value.
Considerations
- Mondelez's Q3 2025 revenue missed analyst expectations, leading to a negative investor reaction and stock price decline.
- High cocoa costs have significantly impacted margins and represent a primary inflation-related challenge for the company’s snack segments.
- The stock experienced a notable decline of approximately 14.6% over the past year, reflecting market concerns over growth prospects and margin sustainability.
Pros
- Kimberly-Clark benefits from a strong and diversified portfolio in personal care products with significant market presence in North America and internationally.
- The company maintains robust financial metrics including a net income of approximately $1.97 billion and a dividend yield near 5%, supporting income investors.
- Kimberly-Clark's stock trades at a forward P/E of about 13.08, indicating relatively attractive valuation compared to industry peers.
Considerations
- The stock has experienced a constrained 52-week trading range with limited upside momentum after peaks near $150, now trading closer to $100.
- Kimberly-Clark faces competitive and cost pressures in personal care and tissue markets that may affect margin expansion.
- Beta of 0.25 indicates low volatility, which may limit gains during strong market rallies for investors seeking growth.
Mondelez (MDLZ) Next Earnings Date
Mondelez International (MDLZ) is scheduled to release its next earnings on April 28, 2026, after market close. This report will cover the Q1 2026 results, with a conference call at 5:00 PM ET. The prior quarter's earnings were reported on February 3, 2026, aligning with the company's typical early-month pattern for quarterly disclosures.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark (KMB) is scheduled to report its Q1 2026 earnings tomorrow, on April 28, 2026, before the market opens. This release will cover the first quarter of 2026, with a conference call at 8:00 AM ET. The prior quarter's results were announced on January 27, 2026, aligning with the company's typical late-January and late-April pattern for quarterly disclosures.
Mondelez (MDLZ) Next Earnings Date
Mondelez International (MDLZ) is scheduled to release its next earnings on April 28, 2026, after market close. This report will cover the Q1 2026 results, with a conference call at 5:00 PM ET. The prior quarter's earnings were reported on February 3, 2026, aligning with the company's typical early-month pattern for quarterly disclosures.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark (KMB) is scheduled to report its Q1 2026 earnings tomorrow, on April 28, 2026, before the market opens. This release will cover the first quarter of 2026, with a conference call at 8:00 AM ET. The prior quarter's results were announced on January 27, 2026, aligning with the company's typical late-January and late-April pattern for quarterly disclosures.
Buy MDLZ or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


